home.aspx
 
EVENTS

APPLY BY 9/6: RA Capital
APPLY BY 9/6: RA CAPITAL'S "THE BUSINESS OF BIOTECHNOLOGY": ADVANCED CONCEPTS SHORT COURSE
October 14-23, 2019
So much of what’s important to success in the biotechnology sector is not as it seems – we have watched many people (including ourselves) learn difficult lessons through trial and error.

BIO Investor Forum
BIO INVESTOR FORUM
October 22-23, 2019
The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event features plenary sessions, business roundtables and therapeutic workshops, company presentations, and BIO One-on-One Partnering&tr...

Uberflip

Uberflip is the world’s #1 Content Experience Platform (CEP). With tools to aggregate all your marketing content, they empower B2B marketing and sales teams to create personalized content experiences to engage accounts, nurture prospects, and convert leads, without the help of IT. It’s their mission to put control back in the hands of marketing teams to deliver high-converting experiences, that put the customer front and center.

RELATED NEWS


Any bleeding results in a decrease in the amount of circulating blood and the disruption of the adequate supply of tissues with oxygen can lead to death. An important measure aimed at correcting the pathological effects of acute blood loss is to restore the globular volume of blood. However, transfusion with erythrocyte mass is not always effective, since after prolonged storage, it can cause additional sludging and thrombosis of the microcirculatory bed, and as a result, deterioration of the bl...
LOBACHEVSKY UNIVERSITY
READ MORE

Researchers in India will soon have their own preprint repository where they can post manuscripts from any discipline. The founders of IndiaRxiv hope it will improve the quality of science in the country. The repository joins a growing number of preprint servers hosting research from a particular region, including Indonesia’s INA-Rxiv and Africa’s AfricArxiv. “The success of the Indonesian and African preprint repositories motivated us to create another one for the global south...

READ MORE

Heat Biologics, Inc. (Nasdaq:HTBX), a leader in the development of gp96-based immunotherapies that are designed to activate a patient’s immune system to fight cancer, announced that it presented topline data from its 94-patient Phase II trial evaluating HS-410 (vesigenurtacel-L) in combination with standard of care, Bacillus Calmette-Guérin (BCG), or as a monotherapy, for the treatment of non-muscle invasive bladder cancer, at the Society of Urologic Oncology Annual Meeting in San A...
HEATBIO
READ MORE

Until now, the study of the immune system has focused almost exclusively on white blood cells, and T cells in particular, as the body's major infection fighters. However, new research published September 4th in the open access journal PLOS Biology by Dr. Anne Fletcher and Dr. Konstantin Knoblich and colleagues, from the Monash Biomedicine Discovery Institute (BDI), has veered away from traditional immunology by turning the spotlight on the structural cells that build and support the immune-r...
PUBLIC LIBRARY OF SCIENCE
READ MORE

We continue to improve our ability to read, write, and edit DNA on larger and larger scales. GP-write wants to gather and coordinate the global enthusiasm around large-scale genome engineering to bring about some major advancements in several areas. Overall, they have the goal to reduce of cost of building and testing large genomes by over 1,000-fold within ten years. This major reduction in cost would require large improvements in methods and technology, but large-scale projects like the synthe...
PHYS.ORG
READ MORE

Noxopharm Limited (ASX:NOX) is an Australian biotechnology company. It’s involved in drug discovery in the fields of oncology and a number of different non-oncology fields. Our first drug to come into the clinic is called NOX66, it’s an anti-cancer drug and its intended to make existing therapies work better....
FINNEWSNETWORK
READ MORE

EVENTS

APPLY BY 9/6: RA Capital
APPLY BY 9/6: RA CAPITAL'S "THE BUSINESS OF BIOTECHNOLOGY": ADVANCED CONCEPTS SHORT COURSE
October 14-23, 2019
So much of what’s important to success in the biotechnology sector is not as it seems – we have watched many people (including ourselves) learn difficult lessons through trial and error.

BIO Investor Forum
BIO INVESTOR FORUM
October 22-23, 2019
The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event features plenary sessions, business roundtables and therapeutic workshops, company presentations, and BIO One-on-One Partnering&tr...